IGF2BP3 and laryngeal squamous cell carcinoma: RBM15‐mediated m6A modification of BAX inhibitor motif containing 6 (TMBIM6) by recruiting IGF2BP3 to promote the progression of laryngeal squamous cell carcinoma [28].